Thomas N. Sager

2.5k total citations
26 papers, 1.0k citations indexed

About

Thomas N. Sager is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Thomas N. Sager has authored 26 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cellular and Molecular Neuroscience, 11 papers in Molecular Biology and 6 papers in Neurology. Recurrent topics in Thomas N. Sager's work include Neuroscience and Neuropharmacology Research (7 papers), Neurotransmitter Receptor Influence on Behavior (7 papers) and Receptor Mechanisms and Signaling (6 papers). Thomas N. Sager is often cited by papers focused on Neuroscience and Neuropharmacology Research (7 papers), Neurotransmitter Receptor Influence on Behavior (7 papers) and Receptor Mechanisms and Signaling (6 papers). Thomas N. Sager collaborates with scholars based in Denmark, United States and Germany. Thomas N. Sager's co-authors include John D. Salamone, Anders Fink‐Jensen, David P.D. Woldbye, Gitta Wörtwein, Eric J. Nunes, Arne Mørk, Ulrica Englund, Lyndsey E. Collins, Elisabetta Vaudano and Morgane Thomsen and has published in prestigious journals such as Journal of Neuroscience, Brain Research and Neuroscience.

In The Last Decade

Thomas N. Sager

26 papers receiving 999 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas N. Sager Denmark	19	537	366	199	170	109	26	1.0k
Patrick L. Stemkowski Canada	18	512 1.0×	564 1.5×	126 0.6×	61 0.4×	104 1.0×	25	1.3k
Kerrie D. Pierce Australia	18	508 0.9×	869 2.4×	49 0.2×	256 1.5×	99 0.9×	31	1.3k
Andrea L.O. Hebb Canada	16	395 0.7×	520 1.4×	97 0.5×	31 0.2×	109 1.0×	44	1.1k
Anne Kästner France	25	489 0.9×	338 0.9×	421 2.1×	27 0.2×	258 2.4×	42	1.7k
Kimberly A. Leite‐Morris United States	20	508 0.9×	278 0.8×	91 0.5×	83 0.5×	161 1.5×	27	888
Joshua T. Dearborn United States	14	158 0.3×	288 0.8×	113 0.6×	68 0.4×	139 1.3×	24	1.0k
Weihua Wan Canada	9	310 0.6×	238 0.7×	43 0.2×	103 0.6×	58 0.5×	9	748
Victoria Akerstrom United States	26	623 1.2×	567 1.5×	124 0.6×	28 0.2×	289 2.7×	38	2.2k
Stephanie Shiers United States	21	447 0.8×	385 1.1×	231 1.2×	16 0.1×	129 1.2×	41	1.5k
Urtė Neniškytė Lithuania	12	364 0.7×	413 1.1×	126 0.6×	153 0.9×	110 1.0×	21	1.9k

Countries citing papers authored by Thomas N. Sager

Since Specialization

Citations

This map shows the geographic impact of Thomas N. Sager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas N. Sager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas N. Sager more than expected).

Fields of papers citing papers by Thomas N. Sager

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas N. Sager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas N. Sager. The network helps show where Thomas N. Sager may publish in the future.

Co-authorship network of co-authors of Thomas N. Sager

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas N. Sager. A scholar is included among the top collaborators of Thomas N. Sager based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas N. Sager. Thomas N. Sager is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sager, Thomas N., et al.. (2016). Factors associated with development of Canine Infectious Respiratory Disease Complex (CIRDC) in dogs in 5 Canadian small animal clinics.. PubMed. 57(1). 46–51. 16 indexed citations

Dencker, Ditte, Gitta Wörtwein, Pia Weikop, et al.. (2011). Involvement of a Subpopulation of Neuronal M₄Muscarinic Acetylcholine Receptors in the Antipsychotic-like Effects of the M₁/M₄Preferring Muscarinic Receptor Agonist Xanomeline. Journal of Neuroscience. 31(16). 5905–5908. 49 indexed citations

Randall, Patrick A., Eric J. Nunes, Colin M. Stopper, et al.. (2011). Stimulant effects of adenosine antagonists on operant behavior: differential actions of selective A2A and A1 antagonists. Psychopharmacology. 216(2). 173–186. 39 indexed citations

Collins, Lyndsey E., Thomas N. Sager, Anette Sams, et al.. (2011). The novel adenosine A2A antagonist Lu AA47070 reverses the motor and motivational effects produced by dopamine D2 receptor blockade. Pharmacology Biochemistry and Behavior. 100(3). 498–505. 33 indexed citations

Jeon, Jongrye, Ditte Dencker, Gitta Wörtwein, et al.. (2010). A Subpopulation of Neuronal M₄Muscarinic Acetylcholine Receptors Plays a Critical Role in Modulating Dopamine-Dependent Behaviors. Journal of Neuroscience. 30(6). 2396–2405. 126 indexed citations

Sager, Thomas N., et al.. (2010). Combination of escitalopram and a 5-HT1A receptor antagonist selectively decreases the extracellular levels of dopamine in the nucleus accumbens relative to striatum through 5-HT2C receptor stimulation; suggestive of antipsychotic potential. Pharmacology Biochemistry and Behavior. 97(3). 479–485. 11 indexed citations

Nunes, Eric J., et al.. (2010). Differential effects of selective adenosine antagonists on the effort-related impairments induced by dopamine D1 and D2 antagonism. Neuroscience. 170(1). 268–280. 69 indexed citations

Mørk, Arne, et al.. (2009). Striatal extracellular dopamine levels and behavioural reversal in MPTP-lesioned mice. Neuroreport. 20(5). 482–486. 9 indexed citations

Betz, Adrienne J., Regina Vontell, Lila T. Worden, et al.. (2009). Effects of the adenosine A2A antagonist KW 6002 (istradefylline) on pimozide-induced oral tremor and striatal c-Fos expression: comparisons with the muscarinic antagonist tropicamide. Neuroscience. 163(1). 97–108. 41 indexed citations

10.

Collins, Lyndsey E., Daniel J. Galtieri, Lise T. Brennum, et al.. (2009). Oral tremor induced by the muscarinic agonist pilocarpine is suppressed by the adenosine A2A antagonists MSX-3 and SCH58261, but not the adenosine A1 antagonist DPCPX. Pharmacology Biochemistry and Behavior. 94(4). 561–569. 30 indexed citations

11.

Witten, Louise, Thomas N. Sager, Kenneth Thirstrup, et al.. (2009). HIF prolyl hydroxylase inhibition augments dopamine release in the rat brain in vivo. Journal of Neuroscience Research. 87(7). 1686–1694. 24 indexed citations

12.

Salamone, John D., Andrew M. Farrar, Laura Font, et al.. (2009). Differential actions of adenosine A1 and A2A antagonists on the effort-related effects of dopamine D2 antagonism. Behavioural Brain Research. 201(1). 216–222. 79 indexed citations

13.

Thomsen, Morgane, Anders Fink‐Jensen, David P.D. Woldbye, et al.. (2008). Effects of acute and chronic aripiprazole treatment on choice between cocaine self-administration and food under a concurrent schedule of reinforcement in rats. Psychopharmacology. 201(1). 43–53. 55 indexed citations

14.

Lapchak, Paul A., Agnete Kirkeby, Justin A. Zivin, & Thomas N. Sager. (2008). Therapeutic window for nonerythropoietic carbamylated-erythropoietin to improve motor function following multiple infarct ischemic strokes in New Zealand white rabbits. Brain Research. 1238. 208–214. 30 indexed citations

15.

Vaudano, Elisabetta, et al.. (2005). KW-6002 protects from MPTP induced dopaminergic toxicity in the mouse. Neuropharmacology. 48(4). 517–524. 72 indexed citations

16.

Sandager‐Nielsen, Karin, Maibritt B. Andersen, Thomas N. Sager, Thomas Werge, & Jørgen Scheel‐Krüger. (2004). Effects of postnatal anoxia on striatal dopamine metabolism and prepulse inhibition in rats. Pharmacology Biochemistry and Behavior. 77(4). 767–774. 10 indexed citations

17.

Torup, Lars, et al.. (2003). Neuroprotective effect of the neurotensin analogue JMV-449 in a mouse model of permanent middle cerebral ischaemia. Neuroscience Letters. 351(3). 173–176. 18 indexed citations

18.

Sager, Thomas N., Simon Topp, Lars Torup, et al.. (2001). Evaluation of CA1 damage using single-voxel 1H-MRS and un-biased stereology: Can non-invasive measures of N-acetyl-asparate following global ischemia be used as a reliable measure of neuronal damage?. Brain Research. 892(1). 166–175. 49 indexed citations

19.

Sager, Thomas N., Anker Jón Hansen, & Henning Laursen. (2000). Correlation between N-Acetylaspartate Levels and Histopathologic Changes in Cortical Infarcts of Mice after Middle Cerebral Artery Occlusion. Journal of Cerebral Blood Flow & Metabolism. 20(5). 780–788. 40 indexed citations

20.

Möller, A, et al.. (2000). Neuroprotective effect of 8-OH-DPAT in global cerebral ischemia assessed by stereological cell counting. European Journal of Pharmacology. 395(2). 137–141. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact